Nordic Process
Chemistry Forum 2018


23 - 25 May, 2018 - Stockholm, Sweden

The 8th Nordic Process Chemistry Forum is the 8th conference in an unbroken chain of biannual events, gathering top scientists in the field from the broader process chemistry/process R&D space.

Plenary Speakers

Frances Arnold Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry Caltech Learn more
Frances Arnold is the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at Caltech, where her research focuses on protein engineering by directed evolution, with applications in alternative energy, chemicals, and medicine. Dr. Arnold pioneered the ‘directed evolution’ of proteins, mimicking Darwinian evolution in the laboratory to create new biological molecules. Her laboratory has developed protein evolution methods that are used widely in industry and basic science to engineer proteins with new and useful properties. Close
Volker Hessel Professor Technical University of Eindhoven Learn more
Previously we (micro-)structured the reactor to operate continuously – the new smart solution is to structure the process media alike the cell does with its organelles. Close
Mark Ford Head of Process Research Bayer AG Crop Science Division Learn more
As Head of Process Research, Bayer AG Crop Science Division, Mark will highlight in his talk the challenges faced when progressing potential crop protection products from Research into Development. Nearly 25 years of process research experience serve as a backdrop for the presentation and discussion.
Nick Turner Professor of Chemical Biology Manchester Institute of Biotechnology Biocentre Learn more
Nick Turner obtained his DPhil in 1985 with Professor Sir Jack Baldwin and from 1985-1987 was a Royal Society Junior Research Fellow, spending time at Harvard University with Professor George Whitesides. He was appointed lecturer in 1987 at Exeter University and moved to Edinburgh in 1995, initially as a Reader and subsequently Professor in 1998. In October 2004 he joined Manchester University as Professor of Chemical Biology where his research group is located in the Manchester Institute of Biotechnology Biocentre (MIB: www.mib.ac.uk). He is Director of the Centre of Excellence in Biocatalysis (CoEBio3) (www.coebio3.org) and a Co-Director of SYNBIOCHEM, the BBSRC Synthetic Biology Research Centre. He is also a co-founder of Ingenza (www.ingenza.com). He is a member of the Editorial Board of ChemCatChem and Advanced Synthesis and Catalysis. His research interests are in the area of biocatalysis with particular emphasis on the discovery and development of novel enzyme catalysed reactions for applications in organic synthesis. His group are also interested in the application of directed evolution technologies for the development of biocatalysts with tailored functions.
Stefan Abele Head of Chemical Development Idorsia Pharmaceuticals Learn more
Stefan studied chemistry in Germany, France, and Switzerland. He obtained his PhD under the guidance of Prof. Dr. D. Seebach at the ETH Zurich in 1999. At Carbogen-Amcis, he had the pleasure to perform or supervise the GMP production of more than 80 Active Pharmaceutical Ingredients (API). In 2006, Stefan set up Chemical Process R&D at Actelion Pharmaceuticals Ltd, responsible for all scientific, technical, organizational, and budgetary aspects. His teams’ tasks were route finding and non-GMP production of APIs, and the development of 2nd generation routes for Actelion’s drugs. After the demerger with J&J on 16 June 2017, Stefan now heads Chemical Development at Idorsia Pharmaceuticals Ltd, adding to Chemical Process R&D the responsibility for development and GMP manufacturing of API’s from preclinical phase to commercial. Stefan has authored more than 65 scientific papers and patent applications and is a frequent speaker at conferences and universities, and in industry. In 2015, his team received the prestigious Sandmeyer Award by the Swiss Chemical Society. Close
David Cole-Hamilton Professor Emeritus of Chemistry St. Andrews Learn more
David Cole-Hamilton was Professor of Chemistry in St. Andrews from 1985, becoming Emeritus in 2014. His main research interests concern the application of organometallic chemistry in homogeneous catalysis and materials chemistry. In homogeneous catalysis he develops: new reactions such as amide hydrogenation to amines, the use of bioresources such as waste natural oils and new methods for the post reaction separation of the product and the catalyst including using ionic liquids, supercritical fluids and flow processes. Close


  • Arrival at IVA (own arrangement)
  • LUNCH buffet is served in the IVA facilities
  • Conference opens in Wallenbergsalen:

    Words of welcome – Karim Engelmark Cassimjee, Hans-Jürgen Federsel
    Reflections on 8th Nordic Process Chemistry Forum – Hans-Jürgen Federsel
    Presentation of IVA – mission, history, achievements – Tuula Teeri, CEO, Johan Weigelt, VP
  • Scientific Session IChairperson Dr Elin Stridfeldt, EnginZyme

    Prof Frances Arnold, California Institute of Technology, Pasadena, USA

    Enzymes by evolution: bringing new chemistry to life
  • Dr Staffan Karlsson, AstraZeneca R&D Gothenburg, Sweden

    A 16 step linear synthesis to API with non UV-active and non-crystalline intermediates with the need to control four chiral stereocentres: A challenge for process development
  • Coffee, tea & refreshment break
  • Dr. Mark James Ford, Bayer Crop Science, Frankfurt/Main, Germany

    The Search For The Holistic Solution
  • Dr. Anders Bergh, Cambrex, Karlskoga, Sweden

    Continuous flow for API and intermediates
  • END of Scientific Session
  • Joint bus transportation to Yasuragi Hasseludden for check-in and installation
  • Finger buffet including beer and wine reception – mingle
  • Close of buffet – continued mingle and bar service
  • Scientific Session IIChairperson Dr Alexey Volkov, EnginZyme

    Prof. Volker Hessel, Eindhoven University of Technology, The Netherlands & University of Adelaide, Australia

    Flow Chemistry and Plasma Processing - System Approaches for Food, Pharma and Health
  • Dr. Stefan Mix, Almac, Belfast, Northern Ireland, UK

    Biocatalytic scale up of chiral amines
  • Prof. Fredrik Björkling, University of Copenhagen, Denmark

    Information about training course on “Chemical Process Development and API Production”
  • Coffee, tea & refreshment break
  • Dr. Stefan Abele, Idorsia Pharmaceuticals, Allschwil, Switzerland

    26 Chemical Steps Revisited: Process R&D and GMP Production of a Novel Antibiotic Compound
  • Dr. Paul Brady, Abel & Imray, London, UK

    The chemical manufacturers of the world: the contrasting developments of the patent systems in China and India over the past 20 years and what it means for you
  • Scientific Session IIIChairperson Dr Peter Hendil-Forssell, EnginZyme

    Dr. Hanna Cotton, Magle Chemoswed, Malmö, Sweden

    Potent compound manufacturing at pilot plant scale. Development of a method for production of the cytostatic agent melflufen
  • Prof. emeritus David Cole-Hamilton, University of St. Andrews, UK

    Where there’s muck there’s brass - (bi)functional molecules from waste bio-oils; chemistry and process
  • Coffee, tea & refreshment break
  • Dr. Karim Engelmark Cassimjee, EnginZyme, Stockholm, Sweden

    Next generation biocatalysis – standardized continuous flow protocols for any enzyme type
  • Dr. Anders Bøgevig, Chemnotia, Stockholm, Sweden

    Benefits of comprehensive route scouting – a customer case
  • FREE TIME FOR OWN ACTIVITIES – e.g. spa facility, gym, exercise, walking tour, jogging
  • Pre-dinner drinks on the veranda or indoors in the restaurant area
  • CONFERENCE DINNER – speeches, entertainment, mingle, post-dinner drinks
  • Scientific Session IVChairperson Dr. Matthew Thompson, EnginZyme

    Dr. Subhash Pithani, AstraZeneca R&D Gothenburg, Sweden

    Using Spinchem® RBR Technology for Immobilized Enzymatic Reactions: A Comparative Study with Traditional Batch Synthesis
  • Prof. Nicholas Turner, University of Manchester, UK

    Organic Synthesis Using Engineered Biocatalysts
  • Coffee, tea & refreshment break
  • Dr. Fernando Huerta, RISE, Södertälje, Sweden

    Innovation in Organic Synthetic Chemistry
  • Summarizing the eventHans-Jürgen Federsel, Karim Engelmark Cassimjee

    Conclusions, personal reflections, the way forward

    Announcement of host for the 2020 Forum

    Words of gratitude and close of 8th Nordic Process Chemistry Forum
  • Bus departure for central Stockholm, Stockholm Bromma Airport (domestic), and Stockholm Arlanda International Airport (expected arrival time 14.30)


Karim Engelmark Cassimjee CEO EnginZyme
Hans-Jürgen Federsel CSO EnginZyme


The Yasuragi conference centre in Saltsjö-Boo close to Stockholm in a south-easterly direction has been chosen as the main location of the Forum. The distance from downtown Stockholm is about 20 minutes by car and the venue is within reach in about 1 hour from Arlanda International Airport. As the name suggests, the concept offered by Yasuragi is Japanese and this features both in the interior design, food, and an elaborate spa and swimming pool section. We will, however, start the proceedings somewhere else – namely in the premises of the Royal Swedish Academy of Engineering Sciences (IVA) in Stockholm (www.iva.se), where we will spend the first afternoon before continuing to the Yasuragi facility.

Book a room at Yasuragi

Exhibit or sponsor

If you’d like to exhibit at NPCF 2018, we offer the opportunity to host a booth. The price is €2500 for the full three days. We also offer sponsorship opportunities of varying sizes.

If you are interested in this, contact us using the email address below.


Contact information


Registration fee: SEK 7300 (~€730)